secwatch / observer
8-K filed February 27, 2024, 6:59 PM ET ticker SBRA CIK 0001492298
earnings confidence high sentiment positive materiality 0.75

Sabra Q4 2023 Normalized FFO $0.32/sh; guides 2024 Normalized FFO $1.34-$1.38, implying 5% YoY growth

Sabra Health Care REIT, Inc.

2023-FY EPS reported $0.06 revenue$647,514,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Sabra Health Care REIT, Inc. reported the fourth quarter of 2023 results: net income $0.07. Guidance initiated.

Period
the fourth quarter of 2023
Net income
$0.07
Guidance
initiated
Result
reported results
Exact text from the filing
Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2023. FOURTH QUARTER 2023 RESULTS AND RECENT EVENTS • Results per diluted common share for the fourth quarter of 2023 were as follows: • Net Income: $0.07
View on SEC.gov

Browse all earnings releases →

Sabra Health Care REIT, Inc. filing history →

Source: SEC EDGAR
accession 0001492298-24-000007
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.